Successful Treatment with Upadacitinib in Concurrent Atopic Dermatitis, Crohn's Disease, Alopecia Areata, and Eosinophilic Gastropathy in a Pediatric Patient

    January 2026 in “ Dermatology Reports ”
    Edoardo Mortato, Ludovico Maria Rao, Marina Aloi, Arnaldo Cioni, Enrico Matteini, Angela Fico, Sara Lambiase, Ruslana Gaeta Shumak, Luca Bianchi, Elena Campione, Laura Diluvio
    Image of study
    TLDR Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.
    A 15-year-old male with atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastroenteropathy showed significant improvement in symptoms and hair regrowth after 16 weeks of treatment with upadacitinib, a JAK-1 inhibitor. This case underscores the potential of JAK inhibitors in treating complex autoimmune disorders with shared pathogenic pathways.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results